Exelixis
EXEL
#1801
Rank
S$14.29 B
Marketcap
S$53.09
Share price
-1.91%
Change (1 day)
12.37%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company